Oxidative Stress and Immune Response in Melanoma: Ion Channels as Targets of Therapy

Alessia Remigante1, Sara Spinelli1, Angela Marino1

  • 1Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98122 Messina, Italy.

Insights

Oxidative stress impacts ion channels, crucial for melanoma progression and immune evasion. Targeting these channels offers a promising therapeutic strategy for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Oxidative stress and immune responses are implicated in melanoma development.
  • Aberrant ion channel expression in tumor cells influences cancer progression and therapy resistance.
  • Ion channels are vital for cell physiology and are modulated by oxidative stress, especially in melanoma.

Purpose of the Study:

  • To review the effects of oxidative stress on ion channels at molecular and cellular levels.
  • To examine the role of ion channels in melanoma progression and immune evasion.
  • To discuss ion channels as potential therapeutic targets in melanoma.

Main Methods:

  • Literature review focusing on oxidative stress, ion channels, and melanoma.
  • Analysis of molecular and cellular mechanisms.
  • Discussion of therapeutic strategies.

Main Results:

  • Oxidative stress significantly affects ion channel function and expression.
  • Ion channels play a role in melanoma cell transformation, progression, and immune evasion.
  • Dysregulated ion channels are linked to therapeutic resistance in melanoma.

Conclusions:

  • Ion channels are critical regulators in melanoma pathogenesis.
  • Targeting ion channels affected by oxidative stress presents a novel therapeutic avenue for melanoma.
  • Further research into ion channel modulation could lead to effective melanoma treatments.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
621
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K